MEDP

SEC source: 0000892251-23-000198 · form4.xml · derivative · entry 2

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 249

Underlying: Common Stock · 249 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: The restricted stock units vest in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024, and December 31, 2024.

F2 · derivative.expiration_date: The restricted stock units vest in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024, and December 31, 2024.

SEC source: 0000892251-23-000197 · form4.xml · derivative · entry 2

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 286

Underlying: Common Stock · 286 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: The restricted stock units vest in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.

F2 · derivative.expiration_date: The restricted stock units vest in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.

SEC source: 0000892251-23-000195 · form4.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,621,857

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $274.415. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000195 · form4.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,639,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.06 to $273.955. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000194 · form4.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,621,857

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $274.415. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000194 · form4.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,639,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.06 to $273.955. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000193 · form4.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,643,114

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $275.91. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000192 · form4.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,643,114

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $275.91. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000193 · form4.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,664,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $274.26 to $279.50. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000192 · form4.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,664,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $274.26 to $279.50. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000191 · form4.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,689,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $275.59 to $279.52. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000189 · form4.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,689,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $275.59 to $279.52. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000187 · form4.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,714,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $275.67 to $279.49. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000186 · form4.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,714,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $275.67 to $279.49. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000185 · form4.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,739,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $277.805. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000184 · form4.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,739,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $277.805. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000185 · form4.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,789,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $279.85. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000184 · form4.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,789,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $279.85. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000183 · form4.xml · nonDerivative · entry 3

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,839,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F5 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $280.10 to $284.11. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000182 · form4.xml · nonDerivative · entry 3

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,839,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $280.10 to $284.11. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000183 · form4.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,856,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $282.00 to $286.53. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000182 · form4.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,856,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $282.00 to $286.53. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000183 · form4.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,889,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $281.20 to $286.67. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000182 · form4.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,889,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $281.20 to $286.67. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000165 · form4.xml · derivative · entry 2

BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2025-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested on February 28, 2022.

SEC source: 0000892251-23-000165 · form4.xml · nonDerivative · entry 1

BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,683

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000892251-23-000148 · form4.xml · derivative · entry 2

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103

Underlying: Common Stock · 103 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 413 restricted stock units, vesting in four approximately equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 413 restricted stock units, vesting in four approximately equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

SEC source: 0000892251-23-000148 · form4.xml · nonDerivative · entry 1

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,710

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0000892251-23-000147 · form4.xml · derivative · entry 2

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94

Underlying: Common Stock · 94 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.

F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.

SEC source: 0000892251-23-000147 · form4.xml · nonDerivative · entry 1

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0000892251-23-000146 · form4.xml · derivative · entry 2

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82

Underlying: Common Stock · 82 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

SEC source: 0000892251-23-000146 · form4.xml · nonDerivative · entry 1

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0000950170-23-049303 · ownership.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,914,947

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on May 1 2023.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $239.77 to $251.58. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000950170-23-049302 · ownership.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,914,947

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 1. 2023.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $239.77 to $251.58. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000950170-23-049303 · ownership.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,976,602

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on May 1 2023.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $253.07 to $257.935. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000950170-23-049302 · ownership.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,976,602

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 1. 2023.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $253.07 to $257.935. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000145 · form4.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,042,255

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 1, 2023.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $254.74 to $271.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000144 · form4.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 6,042,255

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on May 1, 2023.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $254.74 to $271.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000145 · form4.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,179,634

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 1, 2023.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $271.505 to $278.665. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000144 · form4.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 6,179,634

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on May 1, 2023.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $271.505 to $278.665. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000113 · form4.xml · derivative · entry 3

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,782 shares

Expires 2024-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested in full on May 17, 2018.

SEC source: 0000892251-23-000113 · form4.xml · nonDerivative · entry 2

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188

F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $265.185 to $266.43. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000113 · form4.xml · nonDerivative · entry 1

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,970

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000892251-23-000093 · form4.xml · derivative · entry 3

Brady Kevin M. · CIK 0001877121 · CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2024-08-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested in full on August 5, 2019.

SEC source: 0000892251-23-000093 · form4.xml · nonDerivative · entry 2

Brady Kevin M. · CIK 0001877121 · CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

F1 · shares: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

SEC source: 0000892251-23-000093 · form4.xml · nonDerivative · entry 1

Brady Kevin M. · CIK 0001877121 · CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000892251-23-000088 · form4.xml · derivative · entry 3

EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,850 shares

Expires 2026-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested in full on February 28, 2020.

SEC source: 0000892251-23-000088 · form4.xml · nonDerivative · entry 2

EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,854

F1 · shares: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

SEC source: 0000892251-23-000088 · form4.xml · nonDerivative · entry 1

EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,704

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000892251-23-000073 · form4.xml · derivative · entry 2

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206

Underlying: Common Stock · 103 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 413 restricted stock units, vesting in four approximately equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 413 restricted stock units, vesting in four approximately equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.